Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price

Coronavirus (COVID-19) Current Therapy Market 2022 – By Drug Type (Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors), By End-User (Hospitals, Clinics, Home Care), And By Region, Opportunities And Strategies – Global Forecast To 2031

Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery

Starting Price : $5000.00 $3500.00 | Pages : 276 | Published : June 2022 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Coronavirus (COVID-19) Current Therapy Market Definition

The coronavirus (COVID-19) current therapy market consists of sales of drugs and related services by entities (organizations, sole traders and partnerships) that are currently used for the treatment of COVID-19 infection. Coronavirus (COVID-19) current therapy includes repurposed single-drug therapeutics and combination drug therapeutics used in treating COVID-19 patients.  The coronavirus (COVID-19) current therapy market consists of revenue generated by the companies that manufacture coronavirus current therapeutics by the sales of these products which are used in hospitals and clinics, home care, diagnostic laboratories, and research institutions.

Coronavirus disease (COVID-19) is defined as illness caused by a novel coronavirus. Currently, the U.S. Food and Drug Administration (FDA) has approved the antiviral drug remdesivir (Veklury) to treat COVID-19 in hospitalized adults and children who are age 12 and older in the hospital. In addition to this, the FDA has also granted an emergency use authorization for the rheumatoid arthritis drug baricitinib (Olumiant) to treat COVID-19 in some cases and Baricitinib, a pill that works against COVID-19 by reducing inflammation and having antiviral activity. The FDA has also approved monoclonal antibody medications such as sotrovimab and a combination of two antibodies called casirivimab and imdevimab.   Similarly, European Medicine Agency (EMA) approved monoclonal antibodies Regkirona (regdanvimab) and Ronapreve (casirivimab / imdevimab) for COVID-19 treatment.

Book your 30 minutes free consultation with our research experts

Contact Us

Coronavirus (COVID-19) Current Therapy Market Size

The global coronavirus (COVID-19) current therapy market reached a value of nearly $23,466.7 million in 2020. The global coronavirus (COVID-19) current therapy market size is expected to decline from $23,466.7 million in 2020 to $2,346.7 million in 2025 at a rate of -46.3%.

Going forward, the impact of COVID-19 pandemic, aging population, rising prevalence of chronic diseases, new COVID-19 strains, government initiatives, vaccine hesitancy, and an increase in healthcare access, increasing number of clinical trials by key players and academic institutes and fast-track regulatory approvals will drive the growth. Factors that could hinder the growth of the oxygen market in the future include mass vaccination campaigns and variants of COVID-19.

The coronavirus (COVID-19) current therapy market is segmented by drug type into antiviral, monoclonal antibodies, corticosteroid, supplements, antimalarial, interferons and interleukin inhibitors, other anti-infective drugs and others. The antiviral was the largest segment of the coronavirus (COVID-19) current therapy market segmented by drug type, accounting for 33.5% of the total in 2020.

Coronavirus (COVID-19) Current Therapy Market Drivers

The key drivers of the coronavirus (COVID-19) current therapy market include:

Impact Of COVID-19 Pandemic

The outbreak of the COVID-19 pandemic is expected to contribute to the growth of the coronavirus (COVID-19) current therapy market during the forecast period. On March 11, 2020, the World Health Organization (WHO) declared the outbreak as a global pandemic. According to the World Health Organization (WHO), there were 450,229,635 cases of COVID-19 including 6,019,085 deaths reported to WHO as of 10th March 2022.  In early 2020, the countries across the world faced shortages of drugs and the drug manufacturers started ramping up production to meet the global demand. Coronavirus Treatment Acceleration Program (CTAP) is a special emergency program initiated by the FDA for the development of potential COVID-19 therapies to be made available to the patients as quickly as possible.  Therefore, the outbreak of the COVID-19 promoted the growth of the coronavirus (COVID-19) current therapy market.

Coronavirus (COVID-19) Current Therapy Market Restraints

The key restraints on the coronavirus (COVID-19) current therapy market include:

Variants of COVID-19

The rapid evolution of new variants of COVID-19 may negatively impact the growth of the coronavirus (COVID-19) current therapy market. Since December 2019, the outbreak of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus, has spread rapidly around the world. Given the threat of a pandemic, scientists and physicians have been racing to understand this new virus and the pathophysiology of this disease to discover possible treatment regimens and effective therapeutic agents and vaccines. BUT COVID-19 has mutated (changed) over time, resulting in different virus variants. For instance, up until September 2021, the Delta variant was regarded as the most contagious form of the SARS-CoV-2 coronavirus.  In November 2021, the Omicron variant has been reported in several countries, including the South Africa, the Netherlands, the United Kingdom, and Belgium. The World Health Organization (WHO) has issued a warning that the Omicron coronavirus variant poses a high risk of infection outbreaks around the world.  The continuous evolution of the COVID variant raises a question over the safety and efficiency of the treatment developed for COVID-19 over the different variants of coronavirus, thus negatively impacting the market growth. In addition to this, due to evolution of COVID-19 variants there is suspension of various anti-spike Monoclonal Antibodies (Mabs) and this is leading to return on investment, thus affecting the market.

Coronavirus (COVID-19) Current Therapy Market Trends

Major trends influencing the coronavirus (COVID-19) current therapy market include:

Monoclonal Antibody Therapy

Monoclonal antibody therapy is a major trend being followed to develop a short-term way to treat people with COVID-19. Monoclonal antibody therapy involves the infusion of monoclonal antibodies that are similar to the ones synthesized in the human body naturally in response to infection. These are designed in the laboratory to recognize a specific component of this virus and interfere with the virus activity that attaches and enters into human cells.   In this approach of antibody therapy, researchers started isolating antibodies from recovering patients and identifying the best that can neutralize the virus and keeping it from replicating; they then produced these antibodies in bulk in the laboratory. For instance, in October 2021, the US Food and Drug Administration authorized REGEN-COV (casirivimab and imdevimab, administered together) monoclonal antibody therapy as Emergency Use Authorizations (EUAs) for prevention of COVID-19 as a post-exposure prophylaxis for adults and pediatric individuals.  As per January 2022 notice, REGEN-COV is not currently authorized in any U.S. region due to the high frequency of the Omicron variant. Therefore, REGEN-COV may not be administered for treatment or post-exposure prevention of COVID-19 under the Emergency Use Authorization until further notice by the U.S. food and drug administration. In February 2022, FDA issued an emergency use authorization for Bebtelovimab, a new monoclonal antibody for the treatment of COVID-19 that retains activity against the omicron variant.  The International AIDS Vaccine Initiative also estimates that several clinical trials are underway, and more than 70 antibody therapies are being developed to treat COVID-19.

Cell-Based Therapy

Cell-based therapies are being studied extensively for the treatment of moderate to severe phases of COVID-19. Cell-based therapy involves the transplantation of human cells to repair damaged tissue or cells. Cell-based therapies using mesenchymal stem cells are investigational products for COVID-19 treatment. Mesenchymal stem cells are multipotent adult stem cells present in human tissues including the umbilical cord. These cells can self-renew and differentiate into multiple types of tissues that have therapeutic potential and can be used as a promising clinical research agenda in COVID-19 treatment, due to their immunomodulatory and regenerative activities. There are no approved MSC-based approaches for the treatment of COVID-19, although several clinical trials are ongoing at present.  For instance, according to the U.S. National Library of Medicine several clinical trials are ongoing such as Phase 1 study of “Mesenchymal Stem Cells for the Treatment of COVID-19” by Thomas Advanced Medical LLC in US.  Also, Phase 1 study of “MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome” conducted by D'Or Institute for Research and Education in Brazil.

Opportunities And Recommendations In The Coronavirus (COVID-19) Current Therapy Market

Opportunities –The top opportunities in the coronavirus (COVID-19) current therapy market segmented by drug type will arise in the others segment, which will gain $45.9 million of global annual sales by 2025. The top opportunities in segment by end users will arise in the other end users segment, which will gain -$2,176.4 million of global annual sales by 2025. The coronavirus (COVID-19) current therapy market size will gain the most in the Indonesia at -$116.6 million.  

Recommendations –To take advantage of the opportunities, The Business Research Company recommends the coronavirus (COVID-19) current therapy companies to focus on monoclonal antibody therapy, focus on cell-based therapy, focus on antiviral therapy, focus on immunomodulators, focus on public investments, scale up through strategic collaborations, expand in emerging markets, focus on expanding in developed markets, focus on securing long-term supply contracts with healthcare institutions, provide competitively priced offerings, offer value-based pricing, leverage social media to maximize reach, participate in trade shows and events, increase visibility through business websites and healthcare websites and partnerships with end-users.

Coronavirus (COVID-19) Current Therapy Market Segmentation

The coronavirus (COVID-19) current therapy market is segmented by drug type and by end-user.
By Drug Type -
The coronavirus (COVID-19) current therapy is segmented by drug type into:
    • a) Antiviral
    • b) Monoclonal Antibodies
    • c) Corticosteroid
    • d) Supplements
    • e) Antimalarial
    • f) Interferons
    • g) Interleukin Inhibitors
    • h) Other Anti-Infective Drugs
    • i) Others
The antiviral was the largest segment of the coronavirus (COVID-19) current therapy market segmented by drug type, accounting for 35.0% of the total in 2020.
By End user-
The coronavirus (COVID-19) current therapy market is segmented by end user into:
    • a) Hospitals
    • b) Clinics
    • c) Home Care
    • d) Others
The hospitals market was the largest segment of the coronavirus (COVID-19) current therapy market segmented by end-use, accounting for 43.7% of the total in 2020.
By Geography – The coronavirus (COVID-19) current therapy market is segmented by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the global coronavirus (COVID-19) current therapy market, accounting for 44.0% of the total in 2020. It was followed by Asia Pacific, Western Europe and then the other regions.

Coronavirus (COVID-19) Current Therapy Market Competitive Landscape

Major Competitors are:

  • Gilead Sciences, Inc.
  • F. Hoffmann-La Roche AG
  • Ipca Laboratories Limited
  • Zydus Cadila
  • Regeneron Pharmaceuticals, Inc.

    • Other Competitors Include:

  • Sun Pharmaceutical Industries Limited
  • AbbVie
  • Glenmark Pharmaceuticals Limited
  • Eli Lilly and Company
  • Wallace Pharmaceuticals, Inc.
  • He Qi Group Foundation
  • Beijing Jinwofu Bioengineering Technology Company
  • Zhejiang Orient Gene Biotech Co. Ltd
  • Getein Biotech.
  • Hangzhou Biotest Biotech.
  • AmonMed Biotechnology.
  • Hunan Lituo Biotechnology.
  • Vivacheck Lab.
  • Siemens Healthcare Pte. Ltd.
  • Senova.
  • LetsGet Checke.
  • Omega Diagnostics.
  • Abingdon Health.
  • Babylon.
  • Motologic.
  • Novacyt Group.
  • Abbott Laboratories
  • AstraZeneca
  • Pfizer
  • Mylan
  • Zentiva
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Merck & Co.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Amgen
  • Adaptive Biotechnologies
  • Altimmune
  • BioNtech
  • Cytodyn
  • Heat biologics
  • Inovio pharmaceuticals
  • Johnson&Johnson
  • Moderna
  • Novavax
  • Rochi
  • Takeda pharmaceuticals
  • Vaxart
  • Vir Biotechnology
  • Victory Square Health
  • ACRO Biotech
  • Advagen Biotech Ltd
  • Boditech Med, Inc
  • Cellex Inc.
  • CerTest Biotec
  • BATM
  • BioMedomics
  • QuantLease
  • CapeBio
  • Astel Diagnostics
  • Canary Health Technologies
  • Thermo Fisher Scientific
  • CTK Biotech

      • Table Of Contents

      1. Coronavirus (COVID-19) Current Therapy Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Drug Type

      6.3. Segmentation By End Users

      7. Coronavirus (COVID-19) Current Therapy Market Characteristics

      7.1. Market Definition

      7.2. Market Segmentation By Drug Type

      7.2.1. Antiviral

      7.2.2. Monoclonal Antibodies (Mabs)

      7.2.3. Corticosteroid

      7.2.4. Supplements

      7.2.5. Antimalarial

      7.2.6. Interferons And Interleukin Inhibitors

      7.2.7. Other Anti-Infective Drugs

      7.2.8. Others

      7.3. Market Segmentation By End-Users

      7.3.1. Hospitals

      7.3.2. Clinics

      7.3.3. Homecare

      7.3.4. Others

      8. Coronavirus (COVID-19) Current Therapy Market Trends And Strategies

      8.1. Monoclonal Antibody Therapy

      8.2. Cell-Based Therapy

      8.3. Antiviral Therapy

      8.4. Immunomodulators

      8.5. Public Investments

      8.6. Strategic Collaborations

      8.7. AI and machine learning to tackle COVID-19

      8.8. Convalescent Blood Plasma Therapy

      9. Impact Of COVID-19 On The Coronavirus (COVID-19) Current Therapy Market

      9.1. Impact Of Virus Mutations On The Market

      9.2. Government Initiatives And Funding

      9.3. Impact On Companies

      9.4. Impact On Regulatory Framework of Pharmaceutical Products

      9.5. Future Outlook

      10. Global Coronavirus (COVID-19) Current Therapy Market Size And Growth

      10.1. Market Size

      10.2. Historic and Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      10.2.1. Drivers Of The Market 2020 – 2025

      10.2.2. Restraints On The Market 2020 – 2025

      11. Global Coronavirus (COVID-19) Current Therapy Market Segmentation

      11.1. Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      11.2. Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By End-User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      12. Coronavirus (COVID-19) Current Therapy Market, Regional And Country Analysis

      12.1. Global Coronavirus (COVID-19) Current Therapy Market, By Region, Historic and Forecast, 2020 – 2025F, Value ($ Million)

      12.2. Global Coronavirus (COVID-19) Current Therapy Market, By Country, Historic and Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market

      13.1. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulations

      13.1.6. Regulatory Bodies

      13.1.7. Major Associations

      13.1.8. Taxes Levied

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.3. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.4. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.5. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market: Country Analysis

      13.6. China Coronavirus (COVID-19) Current Therapy Market

      13.7. China Coronavirus (COVID-19) Current Therapy Market Overview

      13.7.1. Country Information

      13.7.2. Market Information

      13.7.3. Background Information

      13.7.4. Government Initiatives

      13.7.5. Regulations

      13.7.6. Regulatory Bodies

      13.7.7. Major Associations

      13.7.8. Taxes Levied

      13.7.9. Corporate Tax Structure

      13.7.10. Investments

      13.7.11. Major Companies

      13.8. China Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.9. China Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.10. China Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.11. India Coronavirus (COVID-19) Current Therapy Market

      13.12. India Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.13. India Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.14. India Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.15. Japan Coronavirus (COVID-19) Current Therapy Market

      13.16. Japan Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.17. Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.18. Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.19. Australia Coronavirus (COVID-19) Current Therapy Market

      13.20. Australia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.21. Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.22. Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.23. Indonesia Coronavirus (COVID-19) Current Therapy Market

      13.24. Indonesia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.25. Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.26. Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.27. South Korea Coronavirus (COVID-19) Current Therapy Market

      13.28. South Korea Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.29. South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      13.30. South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      14. Western Europe Coronavirus (COVID-19) Current Therapy Market

      14.1. Western Europe Coronavirus (COVID-19) Current Therapy Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background Information

      14.1.4. Government Initiatives

      14.1.5. Regulations

      14.1.6. Regulatory Bodies

      14.1.7. Major Associations

      14.1.8. Taxes Levied

      14.1.9. Corporate Tax Structure

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.3. Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.4. Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.5. Western Europe Coronavirus (COVID-19) Current Therapy Market: Country Analysis

      14.6. UK Coronavirus (COVID-19) Current Therapy Market

      14.7. UK Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.8. UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.9. UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.10. Germany Coronavirus (COVID-19) Current Therapy Market

      14.11. Germany Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.12. Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.13. Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.14. France Coronavirus (COVID-19) Current Therapy Market

      14.15. France Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.16. France Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      14.17. France Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      15. Eastern Europe Coronavirus (COVID-19) Current Therapy Market

      15.1. Eastern Europe Coronavirus (COVID-19) Current Therapy Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiatives

      15.1.5. Regulations

      15.1.6. Regulatory Bodies

      15.1.7. Major Associations

      15.1.8. Taxes Levied

      15.1.9. Corporate Tax Structure

      15.1.10. Investments

      15.1.11. Major Companies

      15.2. Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      15.3. Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      15.4. Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      15.5. Eastern Europe Coronavirus (COVID-19) Current Therapy Market: Country Analysis

      15.6. Russia Coronavirus (COVID-19) Current Therapy Market

      15.7. Russia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      15.8. Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      15.9. Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      16. North America Coronavirus (COVID-19) Current Therapy Market

      16.1. North America Coronavirus (COVID-19) Current Therapy Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background Information

      16.1.4. Government Initiatives

      16.1.5. Regulations

      16.1.6. Regulatory Bodies

      16.1.7. Major Associations

      16.1.8. Taxes Levied

      16.1.9. Corporate Tax Structure

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      16.3. North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      16.4. North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      16.5. North America Coronavirus (COVID-19) Current Therapy Market: Country Analysis

      16.6. USA Coronavirus (COVID-19) Current Therapy Market

      16.7. USA Coronavirus (COVID-19) Current Therapy Market Overview

      16.7.1. Region Information

      16.7.2. Market Information

      16.7.3. Background Information

      16.7.4. Government Initiatives

      16.7.5. Regulations

      16.7.6. Regulatory Bodies

      16.7.7. Major Associations

      16.7.8. Taxes Levied

      16.7.9. Corporate Tax Structure

      16.7.10. Investments

      16.7.11. Major Companies

      16.8. USA Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      16.9. USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      16.10. USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      17. South America Coronavirus (COVID-19) Current Therapy Market

      17.1. South America Coronavirus (COVID-19) Current Therapy Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulations

      17.1.6. Regulatory Bodies

      17.1.7. Major Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies

      17.2. South America Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      17.3. South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      17.4. South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      17.5. South America Coronavirus (COVID-19) Current Therapy Market: Country Analysis

      17.6. Brazil Coronavirus (COVID-19) Current Therapy Market

      17.7. Brazil Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      17.8. Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      17.9. Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      18. Middle East Coronavirus (COVID-19) Current Therapy Market

      18.1. Middle East Coronavirus (COVID-19) Current Therapy Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background Information

      18.1.4. Government Initiatives

      18.1.5. Regulatory Bodies

      18.1.6. Major Associations

      18.1.7. Taxes Levied

      18.1.8. Corporate Tax Structure

      18.1.9. Investments

      18.1.10. Major Companies

      18.2. Middle East Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      18.3. Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      18.4. Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      19. Africa Coronavirus (COVID-19) Current Therapy Market

      19.1. Africa Coronavirus (COVID-19) Current Therapy Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes Levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 – 2025F, Value ($ Million)

      19.3. Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      19.4. Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, Value ($ Million)

      20. Coronavirus (COVID-19) Current Therapy Global Market Competitive Landscape

      20.1. Company Profiles

      20.2. Gilead Sciences, Inc.

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. F. Hoffmann-La Roche AG

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Ipca Laboratories Limited

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Zydus Cadila

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Regeneron Pharmaceuticals, Inc.

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Coronavirus (COVID-19) Current Therapy Market Pipeline Analysis

      22. Key Mergers And Acquisitions In The Coronavirus (COVID-19) Current Therapy Global Market

      22.1. Sanofi Acquired Translate Bio

      22.2. Merck Acquired OncoImmune

      22.3. Novartis Collaborated With Molecular Partners AG

      22.4. Roche Holding AG Collaborated With Atea Pharmaceuticals

      22.5. Orgenesis Inc. Acquired Koligo Therapeutics, Inc.

      22.6. Sorrento Therapeutics, Inc. Acquired SmartPharm Therapeutics, Inc.

      22.7. Eli Lily and Company Collaborated With Amgen

      22.8. Pfizer Inc. Partnered With Gilead Sciences, Inc.

      22.9. Junshi Biosciences Collaborated With Eli Lilly And Company

      22.10. Neurimmune Partnered With Ethris

      22.11. Abcellera Collaborated With Eli Lilly And Company

      23. Coronavirus (COVID-19) Current Therapy Market Opportunities And Strategies

      23.1. Global Coronavirus (COVID-19) Current Therapy Market In 2025 – Growth Strategies

      23.1.1. Market Trend Based Strategies

      23.1.2. Competitor Strategies

      24. Coronavirus (COVID-19) Current Therapy Market, Conclusions and Recommendations

      24.1. Conclusions

      24.2. Recommendations

      24.2.1. Product

      24.2.2. Place

      24.2.3. Price

      24.2.4. Promotion

      24.2.5. People

      25. Appendix

      25.1. Market Data Sources

      25.2. Research Methodology

      25.3. Currencies

      25.4. Research Inquiries

      25.5. The Business Research Company

      25.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 2: Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 3: Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 4: Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By End-User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 5: Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By End-User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 6: Global Coronavirus (COVID-19) Current Therapy Market, By Region, Historic and Forecast, 2020-2021, 2021 – 2025F, %
    • Table 7: Global Coronavirus (COVID-19) Current Therapy Market, By Region, Historic and Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 8: Global Coronavirus (COVID-19) Current Therapy Market, By Country, Historic and Forecast, 2020-2021, 2021 – 2025F, %
    • Table 9: Global Coronavirus (COVID-19) Current Therapy Market, By Country, Historic and Forecast, 2020-2021, 2021 – 2025F, %
    • Table 10: Asia-Pacific Total Number Of COVID-19 Cases, Deaths, And Tests As On 11/03/2022
    • Table 11: Asia-Pacific Total Number Of COVID-19 Cases, Deaths, And Tests Per Million As On 11/03/2022
    • Table 12: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
    • Table 13: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 14:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 15: Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 16: Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 17: Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 18: Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 19: Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 20: China Total Number Of COVID-19 Cases, Deaths, And Tests As On 11/03/2022
    • Table 21: China Total Number Of COVID-19 Cases, Deaths, And Tests Per Million As On 11/03/2022
    • Table 22: China Population By Age Group, 2016-2026, Thousands
    • Table 23:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 24: China Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 25: China Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 26: China Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 27: China Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 28: China Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 29: India Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 30: India Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 31: India Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 32: India Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 33: India Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 34: Japan Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 35: Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 36: Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 37: Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 38: Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 39: Australia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 40: Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 41: Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 42: Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 43: Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 44: Indonesia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 45: Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 46: Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 47: Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 48: Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 49: South Korea Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 50: South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 51: South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 52: South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 53: South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 54: Western Europe Total Number Of COVID-19 Cases, Deaths, And Tests As On 11/03/2022
    • Table 55: Western Europe Total Number Of COVID-19 Cases, Deaths, And Tests Per Million As On 11/03/2022
    • Table 56: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 57:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 58:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 59: Western Europe Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 60: Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 61: Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 62: Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 63: Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 64: UK Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 65: UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 66: UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 67: UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 68: UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 69: Germany Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 70: Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 71: Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 72: Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 73: Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 74: France Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 75: France Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 76: France Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 77: France Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 78: France Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 79: Eastern Europe Total Number Of COVID-19 Cases, Deaths, And Tests As On 11/03/2022
    • Table 80: Eastern Europe Total Number Of COVID-19 Cases, Deaths, And Tests Per Million As On 11/03/2022
    • Table 81: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 82:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 83: Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 84: Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 85: Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 86: Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 87: Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 88: Russia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 89: Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 90: Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 91: Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 92: Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 93: North America Total Number Of COVID-19 Cases, Deaths, And Tests As On 11/03/2022
    • Table 94: North America Total Number Of COVID-19 Cases, Deaths, And Tests Per Million As On 11/03/2022
    • Table 95: North America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 96:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 97:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 98: North America Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 99: North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 100: North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 101: North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 102: North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 103: USA Total Number Of COVID-19 Cases, Deaths, And Tests As On 11/03/2022
    • Table 104: USA Total Number Of COVID-19 Cases, Deaths, And Tests Per Million As On 11/03/2022
    • Table 105: USA Population By Age Group, 2016-2026, Thousands
    • Table 106:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 107: USA Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 108: USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 109: USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 110: USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 111: USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 112: South America Total Number Of COVID-19 Cases, Deaths, And Tests As On 11/03/2022
    • Table 113: South America Total Number Of COVID-19 Cases, Deaths, And Tests Per Million As On 11/03/2022
    • Table 114: South America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 115:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 116:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 117: South America Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 118: South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 119: South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 120: South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 121: South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 122: Brazil Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 123: Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 124: Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 125: Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 126: Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 127: Middle East Total Number Of COVID-19 Cases, Deaths, And Tests As On 11/03/2022
    • Table 128: Middle East Total Number Of COVID-19 Cases, Deaths, And Tests Per Million As On 11/03/2022
    • Table 129: Middle East Population By Age Group, By Country, 2016-2026, Thousands
    • Table 130:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 131:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 132: Middle East Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 133: Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 134: Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 135: Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 136: Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 137: Africa Total Number Of COVID-19 Cases, Deaths, And Tests As On 11/03/2022
    • Table 138: Africa Total Number Of COVID-19 Cases, Deaths, And Tests Per Million As On 11/03/2022
    • Table 139: Africa Population By Age Group, By Country, 2016-2026, Thousands
    • Table 140:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 141:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 142: Africa Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 143: Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 144: Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 145: Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Table 146: Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Table 147: Global Coronavirus (COVID-19) Current Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 148: Gilead Sciences, Inc. – Financial Overview, 2016 - 2020, $ Billion
    • Table 149: F. Hoffmann-La Roche AG – Financial Overview, 2016 - 2020, $ Billion
    • Table 150: Ipca Laboratories Limited – Financial Overview, 2016 - 2020, $ Billion
    • Table 151: Zydus Cadila – Financial Overview, 2016 - 2020, $ Billion
    • Table 152: Regeneron Pharmaceuticals, Inc. – Financial Overview, 2016 - 2020, $ Billion
    • Table 153: Global Coronavirus (COVID-19) Current Therapy Market, Pipeline Analysis
    • Table 154: Coronavirus (COVID-19) Current Therapy - Market Data Sources

    List Of Figures

      Figure 1: Global Coronavirus (COVID-19) Current Therapy Market Segmentation By Drug Type
    • Figure 2: Global Coronavirus (COVID-19) Current Therapy Market Segmentation By End Users
    • Figure 3: Global Coronavirus (COVID-19) Current Therapy Market, Historic and Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 4: Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 5: Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By End-User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 6: Global Coronavirus (COVID-19) Current Therapy Market, By Region, Historic and Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 7: Global Coronavirus (COVID-19) Current Therapy Market, By Country, Historic and Forecast, 2020 – 2025F, %
    • Figure 8: Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 9: Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 10: Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 11: China Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 12: China Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 13: China Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 14: India Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 15: India Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 16: India Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 17: Japan Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 18: Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 19: Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 20: Australia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 21: Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 22: Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 23: Indonesia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 24: Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 25: Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 26: South Korea Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 27: South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 28: South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 29: Western Europe Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 30: Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 31: Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 32: UK Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 33: UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 34: UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 35: Germany Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 36: Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 37: Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 38: France Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 39: France Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 40: France Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 41: Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 42: Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 43: Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 44: Russia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 45: Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 46: Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 47: North America Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 48: North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 49: North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 50: USA Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 51: USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 52: USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 53: South America Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 54: South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 55: South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 56: Brazil Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 57: Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 58: Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 59: Middle East Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 60: Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 61: Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 62: Africa Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast, 2020-2021, 2021 – 2025F, $ Million
    • Figure 63: Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 64: Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 – 2025F, %
    • Figure 65: Global Coronavirus (COVID-19) Current Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 66: Gilead Sciences, Inc. – Financial Overview, 2016 – 2020, $ Billion
    • Figure 67: F. Hoffmann-La Roche AG – Financial Overview, 2016 – 2020, $ Billion
    • Figure 68: Ipca Laboratories Limited – Financial Overview, 2016 – 2020, $ Billion
    • Figure 69: Zydus Cadila – Financial Overview, 2016 – 2020, $ Billion
    • Figure 70: Regeneron Pharmaceuticals, Inc. – Financial Overview, 2016 – 2020, $ Billion

    The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

    Read More

    The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

    Read More

    Global Anticoagulants Market 2022 – Market Opportunities And Strategies

    Read More

    Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

    Read More

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

    Read More

    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Enzymes Global Market Report 2024 – By Product Type (Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products), By Application (Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications), By End User (Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Protein Inhibitors Global Market Report 2024 – By Product (Protein Kinase Inhibitors, Monoclonal Antibody, Other Products), By Application (Oncology, Inflammatory Diseases, Other Applications), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies ) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Cellular Immunotherapy Global Market Report 2024 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oral Biologics & Biosimilar Drugs Global Market Report 2024 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

    View Report